https://www.selleckchem.com/pr....oducts/ci994-tacedin
Toll-like receptor 4 (TLR4) is increasingly recognized for its ability to govern the etiology and prognostic outcomes of colorectal cancer (CRC) due to its profound immunomodulatory capacity. Despite widespread interest in TLR4 and CRC, no clear analysis of current literature and data exists. Therefore, translational advances have failed to move beyond conceptual ideas and suggestions. We aimed to determine the relationship between TLR4 and CRC through a systematic review and analysis of published literature and datasets. Dat
Like
Comment
Share
